IL15 and neoplasm: While systemic injections of IL-15 or IL-15/IL-15Rα, which lead to elevated serum levels, may put patients at risk for associated toxicities, CAR cells may be utilized as a vehicle to deliver the cytokine directly to the tumor microenvironment where they can exert their beneficial effect while minimizing the systemic effects.